MUNOGENICS
Munogenics is dedicated to developing therapies for the treatment of a wide variety of cancers in both humans and animals. Munogenics is a company that has completed preliminary clinical studies prooving that certain humans do have high cancer killing activity in their immune systems and these individuals can be used to donate a certain portion of their white blood cells as an entire new concept in elminating solid tumors in individuals with cancer. This technology was orginally discovered at W... ake Forest University. It is a development stage company run by two physicians and an experienced finance professional. In addition, the Company has developed an in-vitro, patent pending assay that will determine the cancer killing activity of a person’s immune system. The FDA has given the company an exemption of Phase I clinical trials and is now engaged in Phase II (a) clinical trials. It is our goal that these efforts will ultimately help millions of patients worldwide regain a normal, healthy life free of cancer. We will hold ourselves to the highest standard of integrity and work ethic in the pursuit of this goal.
MUNOGENICS
Industry:
Biotechnology Health Care
Founded:
2007-07-07
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.munogenics.com
Total Employee:
1+
Status:
Active
Contact:
(512) 990-1131
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Homestead RealTracker
Similar Organizations
OncoGenex
OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.
Current Employees Featured
Founder
Official Site Inspections
http://www.munogenics.com
- Host name: 108-167-135-71.unifiedlayer.com
- IP address: 108.167.135.71
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Munogenics"
Home [www.munogenics.com]
Munogenics, Inc. develops, tests, and licenses novel biological methods for treating and preventing malignant diseases in humans. The Company has a proprietary revolutionary …See details»
Munogenics - Crunchbase Company Profile & Funding
Munogenics is dedicated to developing therapies for the treatment of a wide variety of cancers in both humans and animals. Munogenics is a company that has completed preliminary clinical …See details»
Munogenics, Inc. - EquityNet
Munogenics is dedicated to developing therapies for the treatment of a wide variety of cancers in both humans and animals.See details»
Munogenics - Contacts, Employees, Board Members, Advisors
Munogenics has 3 current employee profiles, including President and CEO Beau Raines. Munogenics is dedicated to developing therapies for the treatment of a wide variety of cancers …See details»
Munogenics, Inc. Company Profile | Austin, TX - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Munogenics, Inc. of Austin, TX. Get the latest business insights from Dun & Bradstreet.See details»
Munogenics - Funding, Financials, Valuation & Investors
Jun 8, 2012 · Munogenics is dedicated to developing therapies for the treatment of a wide variety of cancers in both humans and animals.See details»
Munogenics, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Nov 6, 2024 · Explore Munogenics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials.See details»
About GIFT - munogenics.com
GIFT consists of 4 major novel components which distinguish it from other cancer immunotherapies: • Collects donor cells from correct cancer-resistant humans based on …See details»
Munogenics, Inc. in Austin, TX - (512) 990-1235 - Company Profile
Munogenics, Inc. is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»
Beau Raines - President and CEO @ Munogenics
Beau Raines is the President and CEO at Munogenics. Additionally, Beau Raines has had 1 past job as the Clinical Research Advisor & Project Director at Clinical Research Organization (CRO).See details»
Executive Team - munogenics.com
I have never seen anything like this. This is Nobel Prize stuff."See details»
The multiplex network of human diseases | npj Systems Biology …
Apr 23, 2019 · Here we build and analyze the multiplex network of 779 human diseases, which consists of a genotype-based layer and a phenotype-based layer. We show that diseases with …See details»
A resource to explore the discovery of rare diseases and their ...
May 4, 2021 · We assembled a collection of 4166 rare monogenic diseases and linked them to 3163 causative genes, annotated with OMIM and Ensembl identifiers and HGNC symbols.See details»
Current Treatments for Patients with Genetic Obesity - PMC
Mar 2, 2023 · Genetic obesities, including monogenic and syndromic obesities, are rare and complex neuro-endocrine ... Obesity derives from impaired central control of body weight, …See details»
Munogenics - Crunchbase
Munogenics is dedicated to developing therapies for the treatment of a wide variety of cancers in both humans and animals.See details»
The promise of new anti-obesity therapies arising from ... - Nature
Jul 28, 2022 · With the advent of novel pharmacological treatment options emerging for monogenic obesity syndromes that target the central melanocortin pathway, genetic testing is …See details»
2 The State of the Science - National Center for Biotechnology …
Sep 3, 2020 · The thousands of monogenic diseases vary widely in many respects, including the organ systems affected, the age of onset, and the seriousness of disease. Some monogenic …See details»
Munogenics - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Munogenics is dedicated to developing therapies for the treatment of a wide variety of cancers in both humans and animals.See details»
Nuclear Aggregation of Olfactory Receptor Genes Governs Their …
Gene positioning and regulation of nuclear architecture are thought to influence gene expression. Here, we show that, in mouse olfactory neurons, silent olfactory receptor (OR) genes from …See details»
Stefini Stalos - Chief Physician & Medical Officer @ Munogenics ...
Munogenics Gender Female Dr. Steffini Stalos is a Board Certified Pathologist specializing in transfusion medicine with an expertise in blood and bone marrow transfusions.See details»